Experiments using co-cultures of gastric cells and H. pylori can provide insight into the mechanisms of gastric cell adaptation triggered by H. pylori infection. These adaptive mechanisms may be exploited as pharmacological targets and are important for the development of new therapeutic approaches for non-invasive risk control of gastric diseases caused by H. pylori. Further, experiments using specially gene-edited gastric cells co-cultured with H. pylori can investigate these mechanisms in greater depth. To better assist in the study of the mechanisms of H. pylori infection in humans and to understand the interplay between H. pylori and gastric cells (especially GES-1), Ace Infectious provides specialized gastric cell gene editing services, including gene knockdown, gene overexpression and gene knockout of specific genes in gastric cells.